Pubmed ID |
Author |
Year |
Title |
27864985
|
Wang C
|
2017
|
Telomeric repeat-containing RNA (TERRA) related to polycystic ovary syndrome (PCOS).
|
27865940
|
Kabil Kucur S
|
2016
|
Alterations in nasal mucociliary activity in polycystic ovary syndrome.
|
27866938
|
Legro RS
|
2016
|
Ovulation induction in polycystic ovary syndrome: Current options.
|
27867884
|
Shahebrahimi K
|
2016
|
Comparison clinical and metabolic effects of metformin and pioglitazone in polycystic ovary syndrome.
|
27872430
|
Tekin A
|
2016
|
Polycystic ovary syndrome. Are we overlooking something?
|
27877043
|
Blay SL
|
2016
|
Polycystic ovary syndrome and mental disorders: a systematic review and exploratory meta-analysis.
|
27878529
|
Knebel B
|
2017
|
Association between copy-number variation on metabolic phenotypes and HDL-C levels in patients with polycystic ovary syndrome.
|
27882049
|
Ozay AC
|
2016
|
Different Effects of Myoinositol plus Folic Acid versus Combined Oral Treatment on Androgen Levels in PCOS Women.
|
27882052
|
Mancini M
|
2016
|
Myoinositol and D-Chiro Inositol in Improving Insulin Resistance in Obese Male Children: Preliminary Data.
|
27882095
|
Qin W
|
2016
|
Effect of acupoint catgut embedding therapy combined with Chinese medicine for nourishing the kidneys and promoting blood circulation and improving blood glucose and lipid levels as well as the pregnancy rate in obese PCOS patients with infertility.
|
27886515
|
Li S
|
2017
|
Discovery of Novel Lipid Profiles in PCOS: Do Insulin and Androgen Oppositely Regulate Bioactive Lipid Production?
|
27889100
|
Zhao H
|
2017
|
Epigenetic regulation of an adverse metabolic phenotype in polycystic ovary syndrome: the impact of the leukocyte methylation of PPARGC1A promoter.
|
27889187
|
Kosidou K
|
2016
|
Maternal Polycystic Ovary Syndrome and Risk for Attention-Deficit/Hyperactivity Disorder in the Offspring.
|
27890907
|
Adamska A
|
2016
|
Relationship between serum gonadotropin concentrations and thyroid volume in women with polycystic ovary syndrome.
|
27895088
|
Krishnan A
|
2017
|
Hormonal alterations in PCOS and its influence on bone metabolism.
|
27896252
|
Park CH
|
2016
|
Association between serum gonadotropin level and insulin resistance-related parameters in Korean women with polycystic ovary syndrome.
|
27898267
|
Monastra G
|
2017
|
Combining treatment with myo-inositol and D-chiro-inositol (40:1) is effective in restoring ovary function and metabolic balance in PCOS patients.
|
27898283
|
Villarroel C
|
2017
|
Pregestational type 2 diabetes and gestational diabetes exhibit different sexual steroid profiles during pregnancy.
|
27899014
|
Song DK
|
2016
|
Differentiation between polycystic ovary syndrome and polycystic ovarian morphology by means of an anti-M?llerian hormone cutoff value.
|
27899026
|
Uyanikoglu H
|
2017
|
Circulating levels of apoptotic markers and oxidative stress parameters in women with polycystic ovary syndrome: a case-controlled descriptive study.
|
27901182
|
Sahin M
|
2016
|
Does insulin resistance increase thyroid volume in patients with polycystic ovary syndrome?
|
27901631
|
O'Reilly MW
|
2017
|
11-Oxygenated C19 Steroids Are the Predominant Androgens in Polycystic Ovary Syndrome.
|
27902723
|
Li H
|
2016
|
Should All Women with Polycystic Ovary Syndrome Be Screened for Metabolic Parameters?: A Hospital-Based Observational Study.
|
27902766
|
Simmonds MJ
|
2016
|
Physical Properties of Blood Are Altered in Young and Lean Women with Polycystic Ovary Syndrome.
|
27903446
|
Maslyanskaya S
|
2016
|
Polycystic Ovary Syndrome: An Under-recognized Cause of Abnormal Uterine Bleeding in Adolescents Admitted to a Children's Hospital.
|
27904553
|
Mehrabian F
|
2016
|
Comparison of the effects of metformin, flutamide plus oral contraceptives, and simvastatin on the metabolic consequences of polycystic ovary syndrome.
|
27906550
|
Gibson-Helm M
|
2017
|
Delayed Diagnosis and a Lack of Information Associated With Dissatisfaction in Women With Polycystic Ovary Syndrome.
|
27906711
|
Baldauff NH
|
2017
|
Polycystic ovary syndrome in adolescent girls.
|
27907900
|
Cassar S
|
2016
|
Insulin resistance in polycystic ovary syndrome: a systematic review and meta-analysis of euglycaemic-hyperinsulinaemic clamp studies.
|
27908212
|
Zangeneh FZ
|
2017
|
Are CRH & NGF as psychoneuroimmune regulators in women with polycystic ovary syndrome?
|
27908213
|
Karada? C
|
2017
|
Determinants of low bone mineral density in premenopausal polycystic ovary syndrome patients.
|
27908216
|
Tang YL
|
2017
|
Circulating omentin-1 levels in women with polycystic ovary syndrome: a meta-analysis.
|
27908217
|
Ozcan Dag Z
|
2017
|
The evaluation of temperament and quality of life in patients with polycystic ovary syndrome.
|
27908266
|
Markowicz-Piasecka M
|
2016
|
Is metformin a perfect drug? Updates in pharmacokinetics and pharmacodynamics.
|
27908842
|
?zler S
|
2017
|
Role of Versican and ADAMTS-1 in Polycystic Ovary Syndrome.
|
27910716
|
Andrisani A
|
2017
|
Persistent amenorrhea and decreased DHEAS to cortisol ratio after recovery from anorexia nervosa.
|
27910718
|
Perelman D
|
2017
|
Substituting poly- and mono-unsaturated fat for dietary carbohydrate reduces hyperinsulinemia in women with polycystic ovary syndrome.
|
27911105
|
Li YY
|
2017
|
Associations between maternal BMI as well as glucose tolerance and adverse pregnancy outcomes in women with polycystic ovary syndrome.
|
27911121
|
Bicer M
|
2017
|
Endocan is a predictor of increased cardiovascular risk in women with polycystic ovary syndrome.
|
27911471
|
Samimi M
|
2017
|
The effects of coenzyme Q10 supplementation on glucose metabolism and lipid profiles in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial.
|
27914154
|
Luz R
|
2016
|
Short and Long-Term Efficacy of Laparoscopic Ovarian Diathermy in Women with Polycystic Ovary Syndrome.
|
27916865
|
Scott D
|
2016
|
Associations of Vitamin D with Inter- and Intra-Muscular Adipose Tissue and Insulin Resistance in Women with and without Polycystic Ovary Syndrome.
|
27918066
|
?ebkowska A
|
2017
|
Anti-M?llerian hormone and polycystic ovary syndrome.
|
27923166
|
Li J
|
2017
|
A comparative systematic review of Yasmin (drospirenone pill) versus standard treatment options for symptoms of polycystic ovary syndrome.
|
27923406
|
Jahan S
|
2016
|
Ameliorative effects of rutin against metabolic, biochemical and hormonal disturbances in polycystic ovary syndrome in rats.
|
27924288
|
Lee KH
|
2016
|
Hysterectomy due to Abnormal Uterine Bleeding in a 15-year Old Girl with Rubinstein-Taybi Syndrome.
|
27924832
|
Li SY
|
2016
|
Impaired receptivity and decidualization in DHEA-induced PCOS mice.
|
27925160
|
Stridsklev S
|
2017
|
Uterine artery Doppler measurements during first and second trimesters of normal pregnancy.
|
27925712
|
Szczuko M
|
2016
|
Quantitative assessment of nutrition in patients with polycystic ovary syndrome (PCOS)
|
27927075
|
Rajan RK
|
2017
|
Soy isoflavones exert beneficial effects on letrozole-induced rat polycystic ovary syndrome (PCOS) model through anti-androgenic mechanism.
|
27930544
|
Xu X
|
2016
|
Adiponectin/(FBG???FIns) as a predictor of insulin sensitivity and metabolic syndrome in patients with polycystic ovary syndrome.
|
27931980
|
Chaker F
|
2017
|
Polycystic ovary syndrome: A new phenotype in mosaic variegated aneuploidy syndrome?
|
27933387
|
Xue Y
|
2017
|
Effect of vitamin D on biochemical parameters in polycystic ovary syndrome women: a meta-analysis.
|
27936531
|
Heidelbaugh JJ
|
2016
|
Endocrinology Update: Hirsutism.
|
27941184
|
Ga?czy?ski K
|
2016
|
Should we be more aware of endometrial cancer in adolescents?
|
27941732
|
Das RK
|
2016
|
Glycosylated Hemoglobin in Different Levels of BMI.
|
27958630
|
?zer A
|
2016
|
Increased oxidative stress is associated with insulin resistance and infertility in polycystic ovary syndrome.
|
27959602
|
Chen Z-J
|
2016
|
Fresh versus Frozen Embryos in Polycystic Ovary Syndrome.
|
27959603
|
Rosenwaks Z
|
2016
|
Fresh versus Frozen Embryos in Polycystic Ovary Syndrome.
|
27960599
|
Li L
|
2017
|
Association of betatrophin with metabolic characteristics in overweight/obese and lean women with PCOS.
|
27965096
|
Zhang CL
|
2017
|
Deregulation of RUNX2 by miR-320a deficiency impairs steroidogenesis in cumulus granulosa cells from polycystic ovary syndrome (PCOS) patients.
|
27965459
|
Lu C
|
2017
|
Integrated analyses for genetic markers of polycystic ovary syndrome with 9 case-control studies of gene expression profiles.
|
27965723
|
Orio F
|
2016
|
Prevalence of polycystic ovary morphology in a region of South Italy.
|
27965894
|
Butterworth J
|
2016
|
Bariatric Surgery, Polycystic Ovary Syndrome, and Infertility.
|
27966057
|
Sanchez N
|
2016
|
Suitability of the National Health Care Surveys to Examine Behavioral Health Services Associated with Polycystic Ovary Syndrome.
|
27967205
|
Hakim C
|
2017
|
Gestational Hyperandrogenism in Developmental Programming.
|
27974954
|
Madani T
|
2016
|
Is Coasting Valuable in All Patients with Any Cause of Infertility?
|
27976369
|
Brown J
|
2016
|
Clomiphene and other antioestrogens for ovulation induction in polycystic ovarian syndrome.
|
27982680
|
Vejrazkova D
|
2017
|
Distinct response of fat and gastrointestinal tissue to glucose in gestational diabetes mellitus and polycystic ovary syndrome.
|
27983870
|
Osuka S
|
2017
|
Kisspeptin in the Hypothalamus of 2 Rat Models of Polycystic Ovary Syndrome.
|
27984130
|
Belani M
|
2016
|
Dual effect of insulin resistance and cadmium on human granulosa cells - In vitro study.
|
27988256
|
Palomba S
|
2017
|
Oocyte Competence in Women with Polycystic Ovary Syndrome.
|
27988272
|
Serrano Mujica LK
|
2017
|
The impact of postnatal leuprolide acetate treatment on reproductive characteristics in a rodent model of polycystic ovary syndrome.
|
27990089
|
?elik E
|
2016
|
Metabolic and carbohydrate characteristics of different phenotypes of polycystic ovary syndrome.
|
27990221
|
Ribeiro VB
|
2016
|
Polycystic Ovary Syndrome Presents Higher Sympathetic Cardiac Autonomic Modulation that is not altered by Strength Training.
|
27993552
|
Gleicher N
|
2017
|
New PCOS-like phenotype in older infertile women of likely autoimmune adrenal etiology with high AMH but low androgens.
|
27997268
|
Vine DF
|
2017
|
Impaired ApoB-Lipoprotein and Triglyceride Metabolism in Obese Adolescents With Polycystic Ovary Syndrome.
|
27997581
|
Aydos A
|
2016
|
Identification of Polycystic Ovary Syndrome (PCOS) Specific Genes in Cumulus and Mural Granulosa Cells.
|
27998701
|
Kim JY
|
2017
|
Anti-M?llerian Hormone in Obese Adolescent Girls With Polycystic Ovary Syndrome.
|
27999117
|
Handelsman DJ
|
2017
|
Performance of mass spectrometry steroid profiling for diagnosis of polycystic ovary syndrome.
|
27999118
|
Wei D
|
2017
|
Effect of pretreatment with oral contraceptives and progestins on IVF outcomes in women with polycystic ovary syndrome.
|
28001262
|
Andrade VH
|
2016
|
Current aspects of polycystic ovary syndrome: A literature review.
|
28002314
|
Yu HF
|
2016
|
Association between polycystic ovary syndrome and the risk of pregnancy complications: A PRISMA-compliant systematic review and meta-analysis.
|
28003008
|
Tzotzas T
|
2017
|
Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists in the Treatment of Obese Women with Polycystic Ovary Syndrome.
|
28004236
|
Garin MC
|
2017
|
Ghrelin is independently associated with anti-mullerian hormone levels in obese but not non-obese women with polycystic ovary syndrome.
|
28004769
|
Liu Q
|
2016
|
Single-cell analysis of differences in transcriptomic profiles of oocytes and cumulus cells at GV, MI, MII stages from PCOS patients.
|
28006770
|
Chiu WL
|
2017
|
Cardiometabolic Risks in Polycystic Ovary Syndrome: Non-Traditional Risk Factors and the Impact of Obesity.
|
28007842
|
Pergialiotis V
|
2017
|
MANAGEMENT OF ENDOCRINE DISEASE: The impact of subclinical hypothyroidism on anthropometric characteristics, lipid, glucose and hormonal profile of PCOS patients: a systematic review and meta-analysis.
|
28019133
|
Eser B
|
2017
|
The effects of IL-1A and IL-6 genes polymorphisms on gene expressions, hormonal and biochemical parameters in polycystic ovary syndrome.
|
28026098
|
Xia H
|
2016
|
Risk factors for preeclampsia in infertile Chinese women with polycystic ovary syndrome: A prospective cohort study.
|
28028399
|
Jovanovska-Mishevska S
|
2016
|
Indexes of Insulin Resistance in Hyperinsulinemic Polycystic Ovary Syndrome in a Macedonian Cohort of Women of Reproductive Age: A Cross-Sectional Study.
|
28028784
|
Don? S
|
2017
|
Is cardiorespiratory fitness impaired in PCOS women? A review of the literature.
|
28030919
|
Marciniak A
|
2016
|
Cardiovascular system diseases in patients with polycystic ovary syndrome - the role of inflammation process in this pathology and possibility of early diagnosis and prevention.
|
28030942
|
Skowro?ska P
|
2016
|
The role of vitamin D in reproductive dysfunction in women - a systematic review.
|
28031324
|
Ollila ME
|
2017
|
Overweight and obese but not normal weight women with PCOS are at increased risk of Type 2 diabetes mellitus-a prospective, population-based cohort study.
|
28031728
|
Sharif E
|
2017
|
The frequency of polycystic ovary syndrome in young reproductive females in Qatar.
|
28034591
|
McBreairty LE
|
2016
|
Women With Polycystic Ovary Syndrome Have Comparable Hip Bone Geometry to Age-Matched Control Women.
|
28035585
|
Hakimi O
|
2016
|
Effect of Exercise on Ovulation: A Systematic Review.
|
28036005
|
Zhou W
|
2016
|
Bisphenol A and Ovarian Reserve among Infertile Women with Polycystic Ovarian Syndrome.
|
28039871
|
M?nzker J
|
2017
|
High salivary testosterone-to-androstenedione ratio and adverse metabolic phenotypes in women with polycystic ovary syndrome.
|